Development of New Technologies Needed for Studying the Human Microbiome (R01)
The summary for the Development of New Technologies Needed for Studying the Human Microbiome (R01) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Development of New Technologies Needed for Studying the Human Microbiome (R01): -Purpose. The purpose of this FOA is to solicit applications to develop new and improved technologies for obtaining samples for sequencing, by culturing or otherwise isolating for analysis currently uncultivatable organisms from the human microbiota. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism and runs in parallel with an FOA of identical scientific scope, RFA RM-08-011, that solicits applications under the R21 mechanism. -Funds Available and Anticipated Number of Awards. $2 million is available in FY08 for this FOA and the parallel R21 FOA in combination. It is anticipated that 2-4 R01 grants (of duration up to 3 years) and 2-6 R21 grants will be awarded, and that budgets will be negotiated to optimize the number of awards that can be made. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications.
Federal Grant Title: | Development of New Technologies Needed for Studying the Human Microbiome (R01) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | RFA-RM-08-010 |
Type of Funding: | Grant |
CFDA Numbers: | 93.310 |
CFDA Descriptions: | Trans-NIH Research Support |
Current Application Deadline: | No deadline provided |
Original Application Deadline: | Feb 15, 2008 |
Posted Date: | Dec 12, 2007 |
Creation Date: | Dec 12, 2007 |
Archive Date: | Mar 17, 2008 |
Total Program Funding: | $2,000,000 |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- For profit organizations other than small businesses State governments Private institutions of higher education Public and State controlled institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Additional Information on Eligibility
- Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply.
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
[email protected] If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
- • NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
- • NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
- • NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
- • Using Metabolomics to Investigate Biological Pathways and Networks (R01)
- • Assay Development for High Throughput Molecular Screening (R21)
- • Membrane Protein Production and Structure Determination (R01)
- More Grants from the National Institutes of Health
- • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
- • AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)